Table 1.
Demographic and other patient characteristics (SAF)
| Active (n = 122) | Placebo (n = 127) | |
|---|---|---|
| Sex, n (%) | ||
| Male | 53 (43.4) | 67 (52.8) |
| Female | 69 (56.6) | 60 (47.2) |
| Age (y) | ||
| Mean (SD) | 37.6 (12.2) | 35.5 (11.2) |
| Range | 18‐59 | 18‐59 |
| Patients with birch allergy symptoms, n (%) | ||
| Allergic asthma | 33 (27.0) | 29 (23.0) |
| Allergic conjunctivitis | 122 (100.0) | 126 (100.0) |
| Allergic rhinitis | 122 (100.0) | 126 (100.0) |
| Cough/sibilant rhonchi | 34 (27.9) | 41 (32.5) |
| Neurodermatitis | 8 (6.6) | 10 (7.9) |
| Birch allergy diagnostics, mean (SD) | ||
| SPT weal area (mm) | 10.5 (3.1) | 10.9 (3.2) |
| EAST/CAP value (kUA/L) | 25.9 (27.6) | 25.5 (28.7) |
EAST/CAP, Enzyme Allergo Sorbent Test/CAPACITY (Pharmacia ThermoFisher Scientific); kUA/L, kilo units of allergen‐specific IgE per litre; n, number of patients; SAF, Safety Analysis Set; SD, standard deviation; SPT, skin prick test.